Literature DB >> 15233919

Arp2/3 is a negative regulator of growth cone translocation.

Geraldine A Strasser1, Nazimah Abdul Rahim, Kristyn E VanderWaal, Frank B Gertler, Lorene M Lanier.   

Abstract

Arp2/3 is an actin binding complex that is enriched in the peripheral lamellipodia of fibroblasts, where it forms a network of short, branched actin filaments, generating the protrusive force that extends lamellipodia and drives fibroblast motility. Although it has been assumed that Arp2/3 would play a similar role in growth cones, our studies indicate that Arp2/3 is enriched in the central, not the peripheral, region of growth cones and that the growth cone periphery contains few branched actin filaments. Arp2/3 inhibition in fibroblasts severely disrupts actin organization and membrane protrusion. In contrast, Arp2/3 inhibition in growth cones minimally affects actin organization and does not inhibit lamellipodia protrusion or de novo filopodia formation. Surprisingly, Arp2/3 inhibition significantly enhances axon elongation and causes defects in growth cone guidance. These results indicate that Arp2/3 is a negative regulator of growth cone translocation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15233919     DOI: 10.1016/j.neuron.2004.05.015

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  89 in total

Review 1.  The growth cone cytoskeleton in axon outgrowth and guidance.

Authors:  Erik W Dent; Stephanie L Gupton; Frank B Gertler
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-03-01       Impact factor: 10.005

2.  Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration.

Authors:  Brian R Hoover; Miranda N Reed; Jianjun Su; Rachel D Penrod; Linda A Kotilinek; Marianne K Grant; Rose Pitstick; George A Carlson; Lorene M Lanier; Li-Lian Yuan; Karen H Ashe; Dezhi Liao
Journal:  Neuron       Date:  2010-12-22       Impact factor: 17.173

3.  Activation of ADF/cofilin mediates attractive growth cone turning toward nerve growth factor and netrin-1.

Authors:  Bonnie M Marsick; Kevin C Flynn; Miguel Santiago-Medina; James R Bamburg; Paul C Letourneau
Journal:  Dev Neurobiol       Date:  2010-07       Impact factor: 3.964

4.  Arp2/3 complex-deficient mouse fibroblasts are viable and have normal leading-edge actin structure and function.

Authors:  Alessia Di Nardo; Gregor Cicchetti; Hervé Falet; John H Hartwig; Thomas P Stossel; David J Kwiatkowski
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-27       Impact factor: 11.205

5.  RhoA-kinase and myosin II are required for the maintenance of growth cone polarity and guidance by nerve growth factor.

Authors:  Robert P Loudon; Lee D Silver; Hal F Yee; Gianluca Gallo
Journal:  J Neurobiol       Date:  2006-07

6.  RhoA-kinase coordinates F-actin organization and myosin II activity during semaphorin-3A-induced axon retraction.

Authors:  Gianluca Gallo
Journal:  J Cell Sci       Date:  2006-08-15       Impact factor: 5.285

7.  Structure and Function of an Actin-Based Filter in the Proximal Axon.

Authors:  Varuzhan Balasanyan; Kaori Watanabe; William P Dempsey; Tommy L Lewis; Le A Trinh; Don B Arnold
Journal:  Cell Rep       Date:  2017-12-05       Impact factor: 9.423

8.  Iron Deficiency Impairs Developing Hippocampal Neuron Gene Expression, Energy Metabolism, and Dendrite Complexity.

Authors:  Thomas W Bastian; William C von Hohenberg; Daniel J Mickelson; Lorene M Lanier; Michael K Georgieff
Journal:  Dev Neurosci       Date:  2016-09-27       Impact factor: 2.984

9.  Nerve growth factor-induced formation of axonal filopodia and collateral branches involves the intra-axonal synthesis of regulators of the actin-nucleating Arp2/3 complex.

Authors:  Mirela Spillane; Andrea Ketschek; Chris J Donnelly; Almudena Pacheco; Jeffrey L Twiss; Gianluca Gallo
Journal:  J Neurosci       Date:  2012-12-05       Impact factor: 6.167

10.  Growth cone-like waves transport actin and promote axonogenesis and neurite branching.

Authors:  Kevin C Flynn; Chi W Pak; Alisa E Shaw; Frank Bradke; James R Bamburg
Journal:  Dev Neurobiol       Date:  2009-10       Impact factor: 3.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.